Genelux Corporation — Company profile
Healthcare · Biotechnology · United States
Last price 2.1 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 94.11M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. Its lead product candidate is Olvi-Vec (olvimulogene nanivacirepvec), a proprietary modified strain of the vaccinia virus indicated for the treatment of ovarian cancer. It also offers CHOICE, a technology and discovery and development platform; and developed an extensive library of isolated and engineered oncolytic VACV immunotherapeutic product candidates. The company has a licensing agreement with Newsoara BioPharma Co. Ltd. to research, develop, commercialize or exploit Olvi-Vec in China, including Mainland China, Taiwan, Hong Kong, and Macau, for human diagnostic, prophylactic, and therapeutic uses. Genelux Corporation was incorporated in 2001 and is headquartered in Westlake Village, California.
Details
| Name | Genelux Corporation |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 26 |
| Founded | 2001 |
| Ipo Date | 2023-01-26 |
| Ceo | Thomas Zindrick |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Ipo Price | 6.00 |
| Isin | US36870H1032 |
| Cusip | 36870H103 |
| Cik | 1231457 |
| Sic | 2834 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Thomas D. Zindrick J.D. | Chairman, Chief Executive Officer and President |
| Matthew Pulisic M.B.A. | Chief Financial Officer and Principal Financial and Accounting Officer |
| Dr. Joseph Cappello Ph.D. | Chief Technical Officer |
| Dr. Yong Yu Ph.D. | Chief Scientific Officer |
| Eric Groen J.D. | General Counsel, Corporate Secretary, Chief Compliance Officer and Head of Business Development |
| Ralph Smalling B.Sc. | Vice President and Head of Regulatory Affairs |
| Dr. Jason B. Litten M.D. | Chief Medical Officer |
Contact
| Address | 2625 Townsgate Road, Suite 230, Westlake Village, California 91361, United States |
| Phone | 805 267 9889 |
| Website | https://www.genelux.com |